Correlation Between Zaptec AS and Ascelia Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zaptec AS and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zaptec AS and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zaptec AS and Ascelia Pharma AB, you can compare the effects of market volatilities on Zaptec AS and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zaptec AS with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zaptec AS and Ascelia Pharma.

Diversification Opportunities for Zaptec AS and Ascelia Pharma

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Zaptec and Ascelia is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Zaptec AS and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and Zaptec AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zaptec AS are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of Zaptec AS i.e., Zaptec AS and Ascelia Pharma go up and down completely randomly.

Pair Corralation between Zaptec AS and Ascelia Pharma

Assuming the 90 days trading horizon Zaptec AS is expected to under-perform the Ascelia Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Zaptec AS is 1.89 times less risky than Ascelia Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Ascelia Pharma AB is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,448  in Ascelia Pharma AB on September 13, 2024 and sell it today you would lose (1,115) from holding Ascelia Pharma AB or give up 77.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Zaptec AS  vs.  Ascelia Pharma AB

 Performance 
       Timeline  
Zaptec AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zaptec AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Ascelia Pharma AB 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Zaptec AS and Ascelia Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zaptec AS and Ascelia Pharma

The main advantage of trading using opposite Zaptec AS and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zaptec AS position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.
The idea behind Zaptec AS and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.